About CSL Limited (CSL)
CSL Limited is a Biotechnology company operating in the Healthcare sector.
CSL trades on the Australian Securities Exchange and is classified as a large-cap stock .
Key Statistics
- Current Price
- A$200.73
- Market Cap
- A$96.33B
- 52-Week High
- A$202.13
- 52-Week Low
- A$90.00
- Sector
- Healthcare
- Industry
- Biotechnology
A$1,000 Invested in CSL Limited (CSL)
How much would A$1,000 invested in CSL be worth today?
What would A$1,000 invested in CSL 1 year ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2025 would be worth A$1,154 as of November 2026, representing a +15.4% total return.
What would A$1,000 invested in CSL 3 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2023 would be worth A$916 as of November 2026, representing a -8.4% total return.
What would A$1,000 invested in CSL 5 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2021 would be worth A$726 as of November 2026, representing a -27.4% total return.
What would A$1,000 invested in CSL 10 years ago be worth today?
A A$1,000 investment in CSL Limited (CSL) in 2016 would be worth A$2,299 as of November 2026, representing a +129.8% total return.
What would A$1,000 invested in CSL at IPO be worth today?
A A$1,000 investment in CSL Limited (CSL) at IPO would be worth A$421,790 as of November 2026, representing a +42079.0% total return.
Monthly Returns Heatmap
Over the past 32+ years (389 months), CSL Limited (CSL) has averaged a monthly return of +1.88% with a median return of +1.92%. The stock had 233 positive months (60%) and 155 negative months (40%). The best month in CSL's history was August 1999 with a +42.3% return, while the worst was May 2003 at -23.8%. Historically, August tends to be the strongest month (averaging +4.6%), and May the weakest (-0.3%).
CSL's longest winning streak was 13 consecutive months of gains, while its longest losing streak was 10 consecutive months of losses. The best full year was 2000 with a cumulative return of +67.1%, and the worst was 2002 at -76.5%.
Annual Returns
Over 32 years of trading history, CSL Limited (CSL) has delivered an average annual return of +26.16% with a median return of +28.98%. The compound annual growth rate (CAGR) is +20.84%. The stock posted gains in 24 years (75%) and losses in 8 years (25%).
CSL's best year was 2000 with a +79.86% gain, while the worst was 2002 at -57.52%. The longest streak of consecutive positive years was 7, and the longest losing streak was 2 years. CSL achieved double-digit gains (10%+) in 20 years. It suffered double-digit losses in 3 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +19.29% | A$168.26 | A$200.73 |
| 2025 | -37.47% | A$269.11 | A$168.26 |
| 2024 | -0.43% | A$270.28 | A$269.11 |
| 2023 | +0.91% | A$267.85 | A$270.28 |
| 2022 | +0.13% | A$267.51 | A$267.85 |
| 2021 | +3.72% | A$257.92 | A$267.51 |
| 2020 | +3.72% | A$248.66 | A$257.92 |
| 2019 | +50.75% | A$164.94 | A$248.66 |
| 2018 | +32.64% | A$124.36 | A$164.94 |
| 2017 | +42.66% | A$87.17 | A$124.36 |
| 2016 | -3.02% | A$89.89 | A$87.17 |
| 2015 | +23.71% | A$72.66 | A$89.89 |
| 2014 | +27.86% | A$56.83 | A$72.66 |
| 2013 | +30.10% | A$43.68 | A$56.83 |
| 2012 | +72.12% | A$25.38 | A$43.68 |
| 2011 | -9.44% | A$28.02 | A$25.38 |
| 2010 | +14.38% | A$24.50 | A$28.02 |
| 2009 | -1.61% | A$24.90 | A$24.50 |
| 2008 | -6.14% | A$26.53 | A$24.90 |
| 2007 | +68.81% | A$15.72 | A$26.53 |
| 2006 | +55.88% | A$10.08 | A$15.72 |
| 2005 | +47.73% | A$6.82 | A$10.08 |
| 2004 | +66.28% | A$4.10 | A$6.82 |
| 2003 | -15.65% | A$4.87 | A$4.10 |
| 2002 | -57.52% | A$11.46 | A$4.87 |
| 2001 | +32.65% | A$8.64 | A$11.46 |
| 2000 | +79.86% | A$4.80 | A$8.64 |
| 1999 | +58.62% | A$3.03 | A$4.80 |
| 1998 | +48.33% | A$2.04 | A$3.03 |
| 1997 | +64.57% | A$1.24 | A$2.04 |
| 1996 | +52.32% | A$0.81 | A$1.24 |
| 1995 | +71.40% | A$0.47 | A$0.81 |
Frequently Asked Questions: CSL
What sector is CSL in? ▼
CSL operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has CSL performed historically? ▼
Over 32 years of trading history, CSL has posted gains in 24 years (75% of the time). The best year was 2000 with a +79.9% return. Past performance does not guarantee future results.
How can I invest in CSL? ▼
You can invest in CSL through any brokerage account that offers access to the Australian Securities Exchange. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold CSL.
Last updated: 11/1/2026